- $16.72bn
- $17.04bn
- $4.10bn
- 97
- 51
- 76
- 88
Annual cashflow statement for Hologic, fiscal year end - September 27th, USD millions except per share, conversion factor applied.
2021 September 25th | 2022 September 24th | 2023 September 30th | 2024 September 28th | 2025 September 27th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,870 | 1,302 | 456 | 790 | 566 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 111 | 106 | 369 | 175 | 354 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13 | 454 | 11.8 | 84.1 | -20.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 2,330 | 2,126 | 1,051 | 1,285 | 1,057 |
| Capital Expenditures | -163 | -127 | -150 | -140 | -152 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,167 | -79.1 | -1.9 | -641 | -330 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,330 | -206 | -152 | -781 | -483 |
| Financing Cash Flow Items | -57.9 | -284 | -32.4 | -20 | -23.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -530 | -756 | -483 | -1,109 | -777 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 469 | 1,169 | 416 | -596 | -201 |